Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Evaluation of a bladder tumor antigen test as a screening test for transitional cell carcinoma of the lower urinary tract in dogs.

Henry CJ, Tyler JW, McEntee MC, Stokol T, Rogers KS, Chun R, Garrett LD, McCaw DL, Higginbotham ML, Flessland KA, Stokes PK.

Am J Vet Res. 2003 Aug;64(8):1017-20.

PMID:
12926595
2.
3.
4.

The BTA stat test: a tumor marker for the detection of upper tract transitional cell carcinoma.

Walsh IK, Keane PF, Ishak LM, Flessland KA.

Urology. 2001 Oct;58(4):532-5.

PMID:
11597532
5.

Collagen N-telopeptide excretion in men: the effects of age and intrasubject variability.

Orwoll ES, Bell NH, Nanes MS, Flessland KA, Pettinger MB, Mallinak NJ, Cain DF.

J Clin Endocrinol Metab. 1998 Nov;83(11):3930-5.

PMID:
9814471
6.

Hormone replacement therapy in postmenopausal women: urinary N-telopeptide of type I collagen monitors therapeutic effect and predicts response of bone mineral density.

Chesnut CH 3rd, Bell NH, Clark GS, Drinkwater BL, English SC, Johnson CC Jr, Notelovitz M, Rosen C, Cain DF, Flessland KA, Mallinak NJ.

Am J Med. 1997 Jan;102(1):29-37.

PMID:
9209198
7.

Reliability of the Fagerstrom Tolerance Questionnaire and the Fagerstrom Test for Nicotine Dependence.

Pomerleau CS, Carton SM, Lutzke ML, Flessland KA, Pomerleau OF.

Addict Behav. 1994 Jan-Feb;19(1):33-9.

8.

The female weight-control smoker: a profile.

Pomerleau CS, Ehrlich E, Tate JC, Marks JL, Flessland KA, Pomerleau OF.

J Subst Abuse. 1993;5(4):391-400.

9.

Relationship of Tridimensional Personality Questionnaire scores and smoking variables in female and male smokers.

Pomerleau CS, Pomerleau OF, Flessland KA, Basson SM.

J Subst Abuse. 1992;4(2):143-54.

10.

Controlled dosing of nicotine via an Intranasal Nicotine Aerosol Delivery Device (INADD).

Pomerleau OF, Flessland KA, Pomerleau CS, Hariharan M.

Psychopharmacology (Berl). 1992;108(4):519-26.

Supplemental Content

Loading ...
Support Center